Medical and Pharmaceutical Notices




16 DECEMBER 2004 NEW ZEALAND GAZETTE, No. 166 4153

Practitioners Act 1995, for a three-year term of office, or
until the business of the tribunal commences, whichever
comes first, commencing from the date of this notification.

Dated at Wellington this 29th day of November 2004.
ANNETTE KING, Minister of Health.

go8265


Medicines Act 1981

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product: Garnier Fructis Anti-dandruff Shampoo
Active Ingredient: Pyrithione zinc 0.9897% equivalent to 10mg/mL (supplied as a mixture of 48% Pyrithione zinc and 52% water)
Dosage Form: Shampoo
New Zealand Sponsor: L’Oreal New Zealand Limited
Manufacturer: L’Oreal Manufacturing (UK) Limited, Talbot Green, Glamorgan, South Wales, United Kingdom

Dated this 9th day of December 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8338

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Salapin
Active Ingredient: Salbutamol sulphate 0.482mg/mL
Dosage Form: Syrup
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland

Product: Xalacom
Active Ingredients: Latanoprost 50µg/mL
Timolol maleate 6.83mg/mL equivalent to timolol 5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pharmacia NV/SA, Puurs, Belgium

Dated this 9th day of December 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8339

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Alvesco
Active Ingredient: Ciclesonide 160µg/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: St Ives Medical
Manufacturer: 3M Health Care (UK) Limited, Loughborough, Leicestershire, England

Product: Alvesco
Active Ingredient: Ciclesonide 40µg/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: St Ives Medical
Manufacturer: 3M Health Care (UK) Limited, Loughborough, Leicestershire, England

Product: Alvesco
Active Ingredient: Ciclesonide 80µg/dose
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: St Ives Medical
Manufacturer: 3M Health Care (UK) Limited, Loughborough, Leicestershire, England



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2004, No 166


Gazette.govt.nz PDF NZ Gazette 2004, No 166





✨ LLM interpretation of page content

🏥 Reappointments to the Medical Practitioners Disciplinary Tribunal (continued from previous page)

🏥 Health & Social Welfare
29 November 2004
Medical Practitioners Disciplinary Tribunal, Reappointments
  • ANNETTE KING, Minister of Health

🏥 Consent to the Distribution of a New Related Product

🏥 Health & Social Welfare
9 December 2004
Medicines Act 1981, Distribution Consent, Garnier Fructis Anti-dandruff Shampoo
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
9 December 2004
Medicines Act 1981, Distribution Consent, Salapin, Xalacom
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
9 December 2004
Medicines Act 1981, Distribution Consent, Alvesco
  • DON MATHESON, Deputy Director-General, Public Health